Power-speed-endurance Profile (Cycling/Rowing) : Optimize Performance of the French Athletes at the Paris Olympics 2024
THPCA2024
Description and Determinants of the Power-speed-endurance Profile (PVE) in Cycling and Rowing to Optimize the Performance of the French Athletes at the Paris Olympics 2024
2 other identifiers
interventional
19
1 country
3
Brief Summary
As part of the preparation at the Paris 2024 Olympic Games, the French rowing and cycling federations and a consortium of researchers met to reach an ultimate goal: to increase the number of medals in these two disciplines for Paris 2024 Olympics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy-volunteers
Started Nov 2021
Longer than P75 for not_applicable healthy-volunteers
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 29, 2021
CompletedFirst Submitted
Initial submission to the registry
February 2, 2022
CompletedFirst Posted
Study publicly available on registry
April 6, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 11, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 11, 2024
CompletedOctober 26, 2024
October 1, 2024
2.7 years
February 2, 2022
October 24, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Maximum force produced at zero speed in a fatigue-free condition
F0i measurement
Month : 3
Speed in a fatigue-free condition
V0i measurement
Month : 3
Maximum force produced at zero speed at the end of the 3 min.
F0e measurement
Month : 3
Speed up produced at the end of the 3 min.
V0e measurement
Month : 3
Secondary Outcomes (24)
Maximal oxygen uptake (VO2max)
At inclusion
Maximal Ventilation (VEmax)
At inclusion
Cardiac output (QCmax)
At inclusion
Maximal cardiac frequency (fcmax)
At inclusion
Fibre type determination
Month : 2
- +19 more secondary outcomes
Study Arms (1)
Track cyclists and rowers (males and females)
EXPERIMENTALAll female and male rowing and track cycling athletes at the national or international national or international level, registered in a selection process and likely to represent France at the likely to represent France at the 2024 Olympics will be asked to take part to take part in this study.
Interventions
Subjects will be subjected to mild hypoxia simulating an altitude of 1750 m (normobaric hypoxia). Hypoxia decreases oxygen supply to tissue and limit exercise capacity. For this, the subjects will inhale a gas mixture depleted in oxygen (enriched in nitrogen). The barometric pressure at 1500 m being 621 mmHg, PIO2 at this altitude (PIO2 = (621 - 47) x 21%) is 120.5 mmHg. For sea level altitude where the barometric pressure is 760 mmHg, the hypoxic gas mixture should contain (x = 120.5 / (760 - 47)) 16.8% O2. Thus, by inhaling a gas mixture that is oxygen-depleted from 21 to 16.8%, subjects (will simulate the altitude of 1750 and) will experience the equivalent of a 20% reduction in oxygen supply.
Eligibility Criteria
You may qualify if:
- experienced, well-trained (national to international level) rowers and cyclists
- written consent
You may not qualify if:
- taking medications interfering with measured parameters
- contraindication to competitive sport practice
- currently participating in an other structured exercise program
- muscular, bone or joint injuries
- neurologic disease
- pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
CEPART
Le Bourget-du-Lac, 73370, France
Chu Nantes
Nantes, 44000, France
Chu Saint-Etienne
Saint-Etienne, 42055, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Léonard FEASSON, PhD
CHU SAINT-ETIENNE
- STUDY DIRECTOR
Laurent MESSONNIER, PhD
Université Savoie Mont Blanc, CHAMBERY
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 2, 2022
First Posted
April 6, 2022
Study Start
November 29, 2021
Primary Completion
August 11, 2024
Study Completion
August 11, 2024
Last Updated
October 26, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share